This week’s chart is pulled from the same analysis we did last week. Last week we introduced the concept of a biomarker quadrant showing Hot, Common, Emerging, and Under-performing biomarkers by usage since first introduced. This week we want to simplify...
In a follow on to our trial filtering changes we made in February, this week we have added a couple more options to trial filtering: Filtering biomarkers to those used as outcome and safety measures Filtering trials to only those with results Insights view of...
This week’s Chart of the Week is an interesting one. We will most likely have a follow up after further analysis of the data from BiomarkerBase. Basically, the chart shows the total commercial usage of a biomarker by company count since the biomarkers first...
Anyone involved in biomarkers knows how imperative it is to stay informed about biomarker developments. Here at Amplion, we aggregate and annotate cutting edge biomarker information and publish it in BiomarkerBase, so you can stay up to date on the clinical biomarker...
In our Charts of the Week over the last several weeks we have been analyzing the use of unique biomarkers by pharmaceutical companies. We are extending that analysis today with a look at the biomarker discovery activity of pharma companies as compared with the number...
